EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Autophagy in cancer development, immune evasion, and drug resistance

Xuegang Niu, Qi You, Kaijian Hou, Yu Tian, Penghui Wei, Yang Zhu, Bin Gao, Milad Ashrafizadeh, Amir Reza Aref, Alireza Kalbasi, Israel Cañadas, Gautam Sethi und 5 weitere

Drug Resistance Updates · 2025-01 · 78 · 101170

DOI: 10.1016/j.drup.2024.101170 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Resistance Updates, 2025-01. Verfasst von Xuegang Niu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Neurosurgery Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China; Depart…. Hauptthemen laut MEDLINE: Autophagy, Neoplasms, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 237-mal zitiert (Crossref) und nennt 415 Literaturangaben. Gefördert von: NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Macroautophagy/autophagy is a highly conserved evolutionary mechanism involving lysosomes for the degradation of cytoplasmic components including organelles. The constitutive, basal level of autophagy is fundamental for preserving cellular homeostasis; however, alterations in autophagy can cause disease pathogenesis, including cancer. The role of autophagy in cancer is particularly complicated, since this process acts both as a tumor suppressor in precancerous stages but facilitates tumor progression during carcinogenesis and later stages of cancer progression. This shift between anti-tumor and pro-tumor roles may be influenced by genetic and environmental factors modulating key pathways such as those involving autophagy-related proteins, the PI3K-AKT-MTOR axis, and AMPK, which often show dysregulation in tumors. Autophagy regulates various cellular functions, including metabolism of glucose, glutamine, and lipids, cell proliferation, metastasis, and several types of cell death (apoptosis, ferroptosis, necroptosis and immunogenic cell death). These multifaceted roles demonstrate the potential of autophagy to affect DNA damage repair, cell death pathways, proliferation and survival, which are critical in determining cancer cells' response to chemotherapy. Therefore, targeting autophagy pathways presents a promising strategy to combat chemoresistance, as one of the major reasons for the failure in cancer patient treatment. Furthermore, autophagy modulates immune evasion and the function of immune cells such as T cells and dendritic cells, influencing the tumor microenvironment and cancer's biological behavior. However, the therapeutic targeting of autophagy is complex due to its dual role in promoting survival and inducing cell death in cancer cells, highlighting the need for strategies that consider both the beneficial and detrimental effects of autophagy modulation in cancer therapy. Hence, both inducers and inhibitors of autophagy have been introduced for the treatment of cancer. This review emphasizes the intricate interplay between autophagy, tumor biology, and immune responses, offering insights into potential therapeutic approaches that deploy autophagy in the cancer suppression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyNeoplasmsDrug Resistance, NeoplasmHumansAnimalsAntineoplastic AgentsSignal TransductionTumor EscapeImmune EvasionTumor Microenvironment

Stichwörter der Autor:innen

Autophagycancer drug resistanceimmunotherapytherapeutic approachestumor microenvironment remodeling

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Neurosurgery, Neurosurgery Research Institute, the First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China; Department of Neurosurgery, National Regional Medical Center, Binhai Campus…
  • Department of Oncological Surgery, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Province 150000, China.
  • School of Public Health(Long Hu people hospital), Shantou University, Shantou, 515000, Guangdong, China.
  • School of Public Health, Benedictine University, Lisle, IL 60532, USA.
  • Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University, Shandong Academy of Medical Sciences, Jinan, Shandong 250000, China.
  • VitroVision Department, DeepkinetiX, Inc, Boston, MA, USA.

Förderung

  • NIGMS NIH HHS

Zitieren

APA

Niu, X., You, Q., Hou, K., Tian, Y., Wei, P., Zhu, Y., Gao, B., Ashrafizadeh, M., Aref, A. R., Kalbasi, A., Cañadas, I., Sethi, G., Tergaonkar, V., Wang, L., Lin, Y., Kang, D., & Klionsky, D. J. (2025). Autophagy in cancer development, immune evasion, and drug resistance. Drug Resistance Updates, 78, 101170. https://doi.org/10.1016/j.drup.2024.101170

Vancouver

Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resistance Updates. 2025;78:101170. doi:10.1016/j.drup.2024.101170

BibTeX
@article{Niu2025,
  author = {Niu, Xuegang and You, Qi and Hou, Kaijian and Tian, Yu and Wei, Penghui and Zhu, Yang and Gao, Bin and Ashrafizadeh, Milad and Aref, Amir Reza and Kalbasi, Alireza and Cañadas, Israel and Sethi, Gautam and Tergaonkar, Vinay and Wang, Lingzhi and Lin, Yuanxiang and Kang, Dezhi and Klionsky, Daniel J},
  title = {Autophagy in cancer development, immune evasion, and drug resistance},
  journal = {Drug Resistance Updates},
  year = {2025},
  volume = {78},
  pages = {101170},
  doi = {10.1016/j.drup.2024.101170}
}
Kostenlos starten →